The cryo-EM structure of the Plasmodium falciparum 20S proteasome and its use in the fight against malaria.
Plasmodium falciparum is the parasite responsible for the most severe form of malaria. Its increasing resistance to existing antimalarials represents a major threat to human health and urges the development of new therapeutic strategies to fight malaria. The proteasome is a protease complex essential in all eukaryotes. Accordingly, inhibition of the Plasmodium 20S proteasome is highly toxic for the parasite at all of its infective and developmental stages. Proteasome inhibitors have antimalarial potential both as curative and transmission blocking agents, but in order to have therapeutic application, they must specifically target the Plasmodium proteasome and not its human counterpart. X-ray crystallography has been widely used to determine structures of yeast and mammalian 20S proteasomes with ligands. However, crystallisation of the Plasmodium proteasome is challenging, as only small quantities of the complex can be directly purified from the parasite. Furthermore, most X-ray structures of proteasome-inhibitor complexes require soaking of crystals with high concentrations of ligand, thus preventing analysis of inhibitor subunit specificity. Instead we chose to determine the Plasmodium falciparum 20S proteasome structure, in the presence of a new rationally designed parasite-specific inhibitor, by high-resolution electron cryo-microscopy and single particle analysis. The resulting map, at a resolution of about 3.6 Å, allows a direct molecular analysis of inhibitor/enzyme interactions. Here we present an overview of this structure, and how it provides valuable information that can be used to assist in the design of improved proteasome inhibitors with the potential to be developed as next-generation antimalarial drugs.
Department of Pathology, Stanford University School of Medicine, CA, USA.|Department of Chemical and Systems Biology, Stanford University School of Medicine, CA, USA.
Hao
H
Li
Department of Pathology, Stanford University School of Medicine, CA, USA.
Matthew
M
Bogyo
MRC Laboratory of Molecular Biology, Cambridge, UK.
Paula C A
PC
da Fonseca
D020285:Cryoelectron Microscopy / Q000379:methods*; D006790:Host-Parasite Interactions / Q000187:drug effects; D006801:Humans; D016778:Malaria, Falciparum / Q000469:parasitology / Q000517:prevention & control*; D008958:Models, Molecular; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000502:physiology / Q000648:ultrastructure; D046988:Proteasome Endopeptidase Complex / Q000737:chemistry / Q000378:metabolism / Q000648:ultrastructure*; D061988:Proteasome Inhibitors / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D011485:Protein Binding; D011487:Protein Conformation
D061988:Proteasome Inhibitors; D046988:Proteasome Endopeptidase Complex

Plasmodium
; cryo-EM; drug design; electron microscopy; inhibitor; malaria; proteasome; single particle; structure